Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Oct 06, 2022 4:00 PM - Oct 07, 2022 11:50 PM

(US Eastern Standard Time)

Advancing Diversity, Equity, and Inclusion Across Life Sciences R&D Meeting

Turn insights into action with meaningful exchange across life sciences research and development (R&D) fields.

Session 8: Perspectives on Patient Engagement in Clinical Trials: Sites, Sponsors, and Mythologies

Session Chair(s)

Jacqueline  Woodruff, MA

Jacqueline Woodruff, MA

President and Medical Anthropologist

AnthroSci, United States

Diana  Foster, BSN, PhD, MSN

Diana Foster, BSN, PhD, MSN

Chief Executive Officer

TOTAL Diversity Clinical Trial Management, United States

Dyan  Bryson

Dyan Bryson

Global Strategic Solutions, Clinical Operations Lead, DEICT

Inspired Health Strategies, United States

This session will showcase three focus areas related to patient engagement in clinical trials. First, we’ll hear the site perspective on how to best support sites in their efforts to expand recruitment and enrollment to underrepresented populations through evidence-based execution. Second, a panel discussion on how companies have made DEI in clinical trials a “way of working” from those who have made the investment and done the hard work. Finally, a discussion on misperceptions related to engaging underrepresented patient populations that will help enable a contemporary reset needed to develop stronger relationships (i.e., partnerships) between patients, communities, and clinical researchers.

Learning Objective :
  • Discuss action-oriented, practical methods to support research sites in enhancing recruitment and enrollment of underrepresented populations
  • Recognize the changes necessary to the R&D business model to make DEI possible for every study
  • Recognize how mythology can play a role in suppressing participation of underrepresented groups

Speaker(s)

Amanda  Rangel, MS

CRO Perspective on Supporting Sites to Enhance the Enrollment of Underrepresented Populations into Clinical Trials - Panelists

Amanda Rangel, MS

83Bar, United States

Senior Vice President, Business Development

Jorge  Hechavarria, PhD, MBA

A View from a Pharmaceutical Company that Made DEI the Way They Do Business - Panelists

Jorge Hechavarria, PhD, MBA

Janssen Pharmaceutical Companies of Johnson & Johnson, United States

Senior Director, Diversity in Clinical Trials, Operations Administration

Cassandra  Smith, MBA

A View from a Pharmaceutical Company that Made DEI the Way They Do Business - Panelists

Cassandra Smith, MBA

Janssen Research & Development, United States

Director, Diversity, Equity, and Inclusion in Clinical Trials

Tesheia H. Johnson, MHS, MBA

The Mythology of Patient Engagement in Clinical Trials - Panelist

Tesheia H. Johnson, MHS, MBA

Yale University School of Medicine, United States

Deputy Director and Chief Operations Officer, YCCI; Director, Clinical Research

Leroy O Perry, PhD

Speaker

Leroy O Perry, PhD

St. Stephens AME Zion Church, United States

Pastor

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.